Acetylshikonin, A Novel CYP2J2 Inhibitor, Induces Apoptosis in RCC Cells via FOXO3 Activation and ROS Elevation
出版年份 2022 全文链接
标题
Acetylshikonin, A Novel CYP2J2 Inhibitor, Induces Apoptosis in RCC Cells via FOXO3 Activation and ROS Elevation
作者
关键词
-
出版物
Oxidative Medicine and Cellular Longevity
Volume 2022, Issue -, Pages 1-20
出版商
Hindawi Limited
发表日期
2022-03-10
DOI
10.1155/2022/9139338
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Parenchymal biopsy in the management of patients with renal cancer
- (2021) Umberto Capitanio et al. WORLD JOURNAL OF UROLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Acetylshikonin Induces Apoptosis in Human Colorectal Cancer HCT-15 and LoVo Cells via Nuclear Translocation of FOXO3 and ROS Level Elevation
- (2021) Heui Min Lim et al. Oxidative Medicine and Cellular Longevity
- CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma
- (2021) Xiong Zou et al. Biomed Research International
- CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway
- (2021) Usama Khamis Hussein et al. Cells
- T‐lymphokine‐activated killer cell‐originated protein kinase (TOPK)‐positive colorectal tumor growth is suppressed by acetylshikonin
- (2020) Ran Zhao et al. BRITISH JOURNAL OF PHARMACOLOGY
- Valorization of Lipopeptides Biosurfactants as Anticancer Agents
- (2020) Marian Rofeal et al. International Journal of Peptide Research and Therapeutics
- p27/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma
- (2019) Arthur W. Currier et al. Scientific Reports
- Cardamonin induces G2/M arrest and apoptosis via activation of the JNK–FOXO3a pathway in breast cancer cells
- (2019) Weiwei Kong et al. CELL BIOLOGY INTERNATIONAL
- Pharmacological properties and derivatives of shikonin—A review in recent years
- (2019) Chuanjie Guo et al. PHARMACOLOGICAL RESEARCH
- Acetylshikonin Sensitizes Hepatocellular Carcinoma Cells to Apoptosis through ROS-Mediated Caspase Activation
- (2019) Ming Hong et al. Cells
- Acetylshikonin induces apoptosis of human leukemia cell line K562 by inducing S phase cell cycle arrest, modulating ROS accumulation, depleting Bcr-Abl and blocking NF-κB signaling
- (2019) Gangping Hao et al. BIOMEDICINE & PHARMACOTHERAPY
- Cytoplasmic p27 is a novel prognostic biomarker and oncogenic protein for nasopharyngeal carcinoma
- (2019) Yaoshu Teng et al. Artificial Cells Nanomedicine and Biotechnology
- CYP2J2 Expression in Adult Ventricular Myocytes Protects Against Reactive Oxygen Species Toxicity
- (2018) Eric A. Evangelista et al. DRUG METABOLISM AND DISPOSITION
- The inhibitory potential of Broussochalcone A for the human cytochrome P450 2J2 isoform and its anti-cancer effects via FOXO3 activation
- (2018) See-Hyoung Park et al. PHYTOMEDICINE
- Recurrence of Renal Cell Cancer After Renal Transplantation in a Multicenter French Cohort
- (2018) Noelle Cognard et al. TRANSPLANTATION
- Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway
- (2018) Zezhao Li et al. Human Cell
- Cytotoxicity and antigenotoxicity evaluation of acetylshikonin and shikonin
- (2018) Ramona Figat et al. DRUG AND CHEMICAL TOXICOLOGY
- ROS Production and ERK Activity Are Involved in the Effects of d-β-Hydroxybutyrate and Metformin in a Glucose Deficient Condition
- (2017) Santosh Lamichhane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of acetylshikonin as the novel CYP2J2 inhibitor with anti-cancer activity in HepG2 cells
- (2017) See-Hyoung Park et al. PHYTOMEDICINE
- Role of cytochrome P450 2J2 on cell proliferation and resistance to an anticancer agent in hepatocellular carcinoma HepG2 cells
- (2017) Geun Hwang et al. Oncology Letters
- Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries
- (2017) Martin C. S. Wong et al. Scientific Reports
- Recurrence in Localized Renal Cell Carcinoma: a Systematic Review of Contemporary Data
- (2017) Jacqueline M. Speed et al. Current Urology Reports
- Medical treatment of renal cancer: new horizons
- (2016) Basma Greef et al. BRITISH JOURNAL OF CANCER
- Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo
- (2016) See-Hyoung Park et al. Oncotarget
- Acetylshikonin Inhibits Human Pancreatic PANC-1 Cancer Cell Proliferation by Suppressing the NF-κB Activity
- (2015) Seok-Cheol Cho et al. Biomolecules & Therapeutics
- Inhibition of cytochrome P450 2J2 by tanshinone IIA induces apoptotic cell death in hepatocellular carcinoma HepG2 cells
- (2015) Yu Jin Jeon et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- FOXO3: A Major Gene for Human Longevity - A Mini-Review
- (2015) Brian J. Morris et al. GERONTOLOGY
- JAK2V617F mediates resistance to DNA damage-induced apoptosis by modulating FOXO3A localization and Bcl-xL deamidation
- (2015) J S Ahn et al. ONCOGENE
- Acetylshikonin induces apoptosis of hepatitis B virus X protein-expressing human hepatocellular carcinoma cells via endoplasmic reticulum stress
- (2014) Jeong Moon et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Potential of decursin to inhibit the human cytochrome P450 2J2 isoform
- (2014) Boram Lee et al. FOOD AND CHEMICAL TOXICOLOGY
- Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53
- (2014) SEE-HYOUN G PARK et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- ROS-mediated JNK/p38-MAPK activation regulates Bax translocation in Sorafenib-induced apoptosis of EBV-transformed B cells
- (2014) GA BIN PARK et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance
- (2013) Meijuan Xu et al. DRUG METABOLISM REVIEWS
- Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells
- (2013) Atsushi Sato et al. Stem Cell Research
- PTEN-regulated AKT/FoxO3a/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells
- (2013) H Luo et al. Cell Death & Disease
- Mitochondria and FOXO3: breath or die
- (2013) Judith Hagenbuchner et al. Frontiers in Physiology
- FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3
- (2012) J. Hagenbuchner et al. JOURNAL OF CELL SCIENCE
- FoxO transcription factors; Regulation by AKT and 14-3-3 proteins
- (2011) Guri Tzivion et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Selective killing of cancer cells by a small molecule targeting the stress response to ROS
- (2011) Lakshmi Raj et al. NATURE
- Hypothyroidism in patients with renal cell carcinoma
- (2010) Manuela Schmidinger et al. CANCER
- Cytochrome P450 2J2 Is Highly Expressed in Hematologic Malignant Diseases and Promotes Tumor Cell Growth
- (2010) C. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity
- (2009) Yunfang Zhang et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid-Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin
- (2009) X.-N. Li et al. DIABETES
- Selective Inhibitors of CYP2J2 Related to Terfenadine Exhibit Strong Activity against Human Cancers in Vitro and in Vivo
- (2009) C. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Repression of BIRC5/Survivin by FOXO3/FKHRL1 Sensitizes Human Neuroblastoma Cells to DNA Damage-induced Apoptosis
- (2009) Petra Obexer et al. MOLECULAR BIOLOGY OF THE CELL
- The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells
- (2009) Dong-yun Shi et al. Molecular Cancer
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Natural compounds for cancer treatment and prevention
- (2009) Stefania Nobili et al. PHARMACOLOGICAL RESEARCH
- Naturally-occurring shikonin analogues – A class of necroptotic inducers that circumvent cancer drug resistance
- (2008) Yanyan Xuan et al. CANCER LETTERS
- Shikonin, Acetylshikonin, and Isobutyroylshikonin Inhibit VEGF-induced Angiogenesis and Suppress Tumor Growth in Lewis Lung Carcinoma-bearing Mice
- (2008) Hyo-Jung LEE et al. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started